Second Line ColoRectal Cancer Therapy in Combination With Combination of FOL- Folinic Acid(Leucovorin), F - Fluorouracil and OX - Oxaliplatin (FOLFOX)

NCT00278889 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

215

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: AZD2171
DRUG: 5-fluorouracil
DRUG: Leucovorin
DRUG: Oxaliplatin
DRUG: Bevacizumab

Sponsor

AstraZeneca